Literature DB >> 17676049

Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells.

Pierre-Alain Girod1, Duc-Quang Nguyen, David Calabrese, Stefania Puttini, Mélanie Grandjean, Danielle Martinet, Alexandre Regamey, Damien Saugy, Jacques S Beckmann, Philipp Bucher, Nicolas Mermod.   

Abstract

Gene transfer in eukaryotic cells and organisms suffers from epigenetic effects that result in low or unstable transgene expression and high clonal variability. Use of epigenetic regulators such as matrix attachment regions (MARs) is a promising approach to alleviate such unwanted effects. Dissection of a known MAR allowed the identification of sequence motifs that mediate elevated transgene expression. Bioinformatics analysis implied that these motifs adopt a curved DNA structure that positions nucleosomes and binds specific transcription factors. From these observations, we computed putative MARs from the human genome. Cloning of several predicted MARs indicated that they are much more potent than the previously known element, boosting the expression of recombinant proteins from cultured cells as well as mediating high and sustained expression in mice. Thus we computationally identified potent epigenetic regulators, opening new strategies toward high and stable transgene expression for research, therapeutic production or gene-based therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17676049     DOI: 10.1038/nmeth1076

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  41 in total

1.  TM6, a novel nuclear matrix attachment region, enhances its flanking gene expression through influencing their chromatin structure.

Authors:  Lusha Ji; Rui Xu; Longtao Lu; Jiedao Zhang; Guodong Yang; Jinguang Huang; Changai Wu; Chengchao Zheng
Journal:  Mol Cells       Date:  2013-07-12       Impact factor: 5.034

Review 2.  A mini review of MAR-binding proteins.

Authors:  Tian-Yun Wang; Zhong-Min Han; Yu-Rong Chai; Jun-He Zhang
Journal:  Mol Biol Rep       Date:  2010-02-22       Impact factor: 2.316

3.  Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction.

Authors:  Fabien Palazzoli; Solenne Bire; Yves Bigot; Florence Bonnin-Rouleux
Journal:  Nat Biotechnol       Date:  2011-07-11       Impact factor: 54.908

Review 4.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

5.  An S/MAR-based L1 retrotransposition cassette mediates sustained levels of insertional mutagenesis without suffering from epigenetic silencing of DNA methylation.

Authors:  Danny Rangasamy
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

6.  Enhanced transgene expression using two β-globin MARs flanking expression cassettes in stably transfected CHO-K1 cells.

Authors:  Jihong Zhang; Junhe Zhang; Shan Cheng; Wenwen Yang; Shijiang Li
Journal:  3 Biotech       Date:  2019-11-02       Impact factor: 2.406

Review 7.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

8.  Toward stable gene expression in CHO cells.

Authors:  Esther Y C Koh; Jessna H M Yeo; Steven C L Ho; Yuansheng Yang
Journal:  Bioengineered       Date:  2014 Sep-Oct       Impact factor: 3.269

9.  Transcription factor CTF1 acts as a chromatin domain boundary that shields human telomeric genes from silencing.

Authors:  Germain Esnault; Stefano Majocchi; Danielle Martinet; Nathalie Besuchet-Schmutz; Jacques S Beckmann; Nicolas Mermod
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

10.  Independent and high-level dual-gene expression in adult stem-progenitor cells from a single lentiviral vector.

Authors:  J Tian; S T Andreadis
Journal:  Gene Ther       Date:  2009-05-14       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.